|
|
Volumn 14, Issue 7, 2015, Pages 445-447
|
|
A β-lactamase inhibitor revival provides new hope for old antibiotics
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
2 HYDROXY 3 (2 THIENYLACETAMIDO) 1,5,2 DIOXABOREPANE 7 ACETIC ACID;
ANTIBIOTIC AGENT;
AVIBACTAM;
AVIBACTAM PLUS CEFTAZIDIME;
AZTREONAM;
BETA LACTAM;
BETA LACTAMASE;
BETA LACTAMASE INHIBITOR;
BORONIC ACID DERIVATIVE;
CARBAPENEM;
CEFTAROLINE;
CEPHALOSPORIN;
CILASTATIN;
CLAVULANIC ACID;
DIAZABICYCLOOCTANE DERIVATIVE;
EXTENDED SPECTRUM BETA LACTAMASE;
IMIPENEM;
MEROPENEM;
METALLO BETA LACTAMASE;
OP 0595;
PENICILLIN DERIVATIVE;
RELEBACTAM;
TAZOBACTAM;
UNCLASSIFIED DRUG;
ANTIINFECTIVE AGENT;
AVIBACTAM, CEFTAZIDIME DRUG COMBINATION;
AZABICYCLO DERIVATIVE;
CEFTAZIDIME;
ANTIBACTERIAL ACTIVITY;
ANTIBIOTIC RESISTANCE;
CARBAPENEM RESISTANT ENTEROBACTERIACEAE;
DEACYLATION;
DRUG ACTIVITY;
DRUG EFFICACY;
ENTEROBACTERIACEAE INFECTION;
ENZYME ACTIVE SITE;
ENZYME BINDING;
ENZYME SYNTHESIS;
HUMAN;
KLEBSIELLA PNEUMONIAE;
METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS;
NONHUMAN;
PHASE 1 CLINICAL TRIAL (TOPIC);
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PRIORITY JOURNAL;
PSEUDOMONAS AERUGINOSA;
SHORT SURVEY;
STRUCTURE ACTIVITY RELATION;
ANIMAL;
DRUG APPROVAL;
DRUG EFFECTS;
PHYSIOLOGY;
UNITED STATES;
ANIMALS;
ANTI-BACTERIAL AGENTS;
AZABICYCLO COMPOUNDS;
BETA-LACTAMASE INHIBITORS;
CEFTAZIDIME;
DRUG APPROVAL;
DRUG RESISTANCE, BACTERIAL;
HUMANS;
UNITED STATES;
|
|
EID: 84934286719
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd4666 Document Type: Short Survey |
|
Times cited : (28)
|
|
References (0)
|
